You are here

Media Coverage

October 15, 2018
The Washington Post

Many scientists are urging a halt to clinical trials that were based partly on falsified data published by a prominent researcher from Harvard Medical School. Deepak Srivastava comments to The Washington Post that it’s time to pause and evaluate such trials.

October 15, 2018
The New York Times

As a story broke out of Harvard Medical School and Brigham and Women’s Hospital involving the falsification of scientific data by Piero Anversa, Benoit Bruneau remarked to The New York Times that this could put into question an entire field of study.

October 9, 2018
CBS New York

CBS New York covers a breakthrough by Yadong Huang, who’s looking at a gene—called apoE4—he and his team believe increases the risk for developing Alzheimer's.

September 24, 2018
The Stem Cellar, CIRM

This blog post highlights a CIRM-funded scientific collaboration between UC Berkeley and Bruce Conklin at Gladstone, during which the researchers found a better way to study certain heart diseases by generating a 3D model of heart tissue.

September 20, 2018
San Francisco Business Times

The San Francisco Business Times explores the latest approaches to an HIV cure by companies and academic researchers. “‘Cure’ overpromises what we can do right now. But the idea of a cure has helped to shape the field,” says Warner Greene.

September 13, 2018

In this Time Magazine article that dives into new possible stem cell and regenerative therapies, Deepak Srivastava talks about his research and how stem cells offer a new way to get to the root cause of a disease and start looking for cures.

September 6, 2018
San Francisco Chronicle

In the final article of a four-part series on stem cells, the San Francisco Chronicle looks into the California Institute for Regenerative Medicine (CIRM). It features Deepak Srivastava, who highlights the importance of CIRM funding for Gladstone research.

The San Francisco Business Times shares the news of Jennifer Doudna, a pioneer of the revolutionary CRISPR genome-editing technology, launching a laboratory at Gladstone.

June 24, 2018
The Mercury News

The Mercury News tells the story of college student Delaney Van Riper who suffers from a progressive neurological disorder. She is participating in a pioneering research study led by Bruce Conklin with the hope of overcoming her condition through the use of the gene-editing technology CRISPR.

June 21, 2018
The New York Times

A recent study suggests viruses might be involved in Alzheimer’s disease. An expert in the field, Lennart Mucke noted to The New York Times, “there have been many speculations that infections contribute to the development of Alzheimer’s. None of them has held up after rigorous cause-effect evaluations.”